Flemington, NJ, United States of America

Christopher W Boyce

This inventor holds 31 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 15 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Schering-Plough Corporation. Active years: 2004-2022.

USPTO Granted Patents = 31 (Patent Applications = 4)

% Patents Active = 45.2

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 10.2

ph-index = 7

Forward Citations = 125(Granted Patents)

Company Filing History:

19 out of 2,405

Merck Sharp + Dohme Corp.

Schering-Plough Corporation

patents

4. 1 out of 52

Pharmacopeia Drug Discovery, Inc.

where one patent can have more than one assignee

Years Active: 2004-2022

Loading Chart...

Areas of Expertise:

Stabilized Amorphous Drug Formulations

Acoustic Fusion

ERK Inhibitors

A2A Antagonist Properties

Alpha2C Adrenergic Receptor Modulators

Functionally Selective Agonists

Biaryl-Spiroaminooxazoline Analogues

Benzimidazole Derivatives

Histamine H3 Antagonists

Non-Imidazole Compounds

Chroman Derivatives

Heterobicyclo-Substituted Compounds

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11344496 - Methods for preparing stabilized amorphous drug formulations using acoustic fusion (2022-05-31),

2. 10759805 - Compounds that are ERK inhibitors (2020-09-01),

3. 10065967 - Compounds that are ERK inhibitors (2018-09-04),

4. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties (2018-07-03),

5. 9884048 - ERK inhibitors (2018-02-06),

6. 9745307 - Compounds that are ERK inhibitors (2017-08-29),

7. 9676780 - [object Object] (2017-06-13),

8. 9469615 - [object Object] (2016-10-18),

9. 9290453 - [object Object] (2016-03-22),

10. 9233979 - Compounds that are ERK inhibitors (2016-01-12),

11. 9226922 - Compounds that are ERK inhibitors (2016-01-05),

12. 9023865 - Compounds that are ERK inhibitors (2015-05-05),

13. 8927559 - [object Object] (2015-01-06),

14. 8569312 - Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators (2013-10-29),

15. 8501747 - Functionally selective alpha2C adrenoreceptor agonists (2013-08-06),

Title: Christopher W Boyce - The Innovative Mind from Flemington

Introduction: Christopher W Boyce is a renowned inventor hailing from Flemington, NJ. His contributions to the field of innovation have been significant and impactful.

Latest Patents: Christopher W Boyce holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his career, Christopher W Boyce has demonstrated a keen ability to identify gaps in the market and develop groundbreaking solutions to address them. His innovative spirit has led to the creation of products that have revolutionized their respective industries.

Collaborations: Christopher W Boyce has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that benefit society.

Conclusion: Christopher W Boyce's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventors. His legacy continues to inspire future generations of innovators.